Home › Funds › STEMPOINT CAPITAL LP › DMRA

STEMPOINT CAPITAL LP position in DMRA

DAMORA THERAPEUTICS INC · Health Care

STEMPOINT CAPITAL LP reported holding 506,067 shares of DMRA (DAMORA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 2.16% of its reported portfolio and ranking #18 among its reported holdings. STEMPOINT CAPITAL LP has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)506.07K sh
Reported value held$10.77M
Portfolio Weight2.16%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How STEMPOINT CAPITAL LP's DMRA position evolved

STEMPOINT CAPITAL LP first disclosed a stake in DMRA in Q2 2026 at 216,194 shares (US$5.6M). The position peaked in Q3 2026 at 506,067 shares, worth US$10.8M. Across 2 filings, STEMPOINT CAPITAL LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 506,067 shares valued at US$10.8M — an increase of 289,873 shares quarter over quarter.. Notable position changes include a 134% increase in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 216.19K $5.62M New
Q3 2026 506.07K $10.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMRA and 13F data

DMRA (DAMORA THERAPEUTICS INC) is a Health Care company. 91 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Venrock Adviser, LLC (US$93.7M), Avoro Capital Advisors LLC (US$80.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMRA

All DMRA fund holders →

FAQ

How long has STEMPOINT CAPITAL LP held DMRA?

STEMPOINT CAPITAL LP has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is STEMPOINT CAPITAL LP's current position in DMRA?

As of Q3 2026, STEMPOINT CAPITAL LP holds 506.07K shares of DMRA (DAMORA THERAPEUTICS INC), valued at $10.77M, representing 2.16% of its reported portfolio and ranking #18.

Has STEMPOINT CAPITAL LP been buying or selling DMRA?

In the latest 13F filing (Q3 2026), STEMPOINT CAPITAL LP increased its position in DMRA. The position peaked in Q3 2026 at 506.07K shares.

Which other funds hold DMRA?

Other major institutional holders of DMRA include Fairmount Funds Management LLC, Venrock Adviser, LLC, Avoro Capital Advisors LLC, among 91 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.